3 Recruiting Trials

Clinical Trials for Stroke in Nebraska

3 clinical trials for Stroke are currently recruiting participants at study sites in Nebraska. Study-related care is provided at no cost.

Showing 3 of 3 recruiting Stroke trials in Nebraska

The CONFORM Pivotal Trial
NA Birmingham, Alabama +4 sites NCT05147792
Recruiting
Encore PFO Closure Device - The PerFOrm Trial
NA Little Rock, Arkansas +4 sites NCT05537753
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
PHASE3 Birmingham, Alabama +4 sites NCT03907046
Recruiting

Stroke clinical trials in Nebraska: common questions

How many Stroke clinical trials are recruiting in Nebraska?
TrialFinder currently lists 3 recruiting Stroke clinical trials with study sites in Nebraska. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Stroke clinical trials located in Nebraska?
Sites for these Stroke trials are spread across Nebraska. Open any trial to see its full list of participating locations and contact details.
Do I need insurance to join a Stroke clinical trial in Nebraska?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Stroke trials in Nebraska also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Stroke clinical trial in Nebraska?
Each study sets its own criteria based on age, Stroke diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Stroke trials near you in Nebraska.

Get Matched — Free
No insurance required

Stroke trials cover thrombolytic agents, mechanical thrombectomy techniques, neuroprotective drugs, and intensive rehabilitation programmes for acute and chronic stroke.

All Stroke trials →